United States: Intellectual Property

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
UK High Court Upholds Takeda’s Lisdexamfetamine SPC: Will The CJEU Agree?
The UK High Court has ruled on whether lisdexamfetamine (LDX), a pro-drug with no therapeutic activity before conversion to dextroamphetamine, can be considered an "active ingredient" for supplementary protection certificate purposes. This decision addresses a critical question in pharmaceutical patent law that has produced divergent outcomes across European jurisdictions and is currently before the CJEU in multiple pending referrals.
United States IP
JA
J A Kemp LLP
Article
The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print
Researchers routinely use AI tools like AlphaFold and Schrödinger's software without scrutinizing license agreements that contain restrictions on commercial use, confidentiality, and mandatory disclosure requirements. These overlooked terms can create significant legal obstacles when translating academic innovations into commercial products, affecting everything from sponsored research agreements to patent filings and university spinouts.
United States IP
FH
Foley Hoag LLP
Article
Intellectual Property Strategy In An Era Of Foreign Clinical Trials
Biotech companies conducting early-stage biologics trials outside the United States face complex intellectual property challenges that can significantly impact their ability to secure U.S. market exclusivity. Foreign clinical trial registrations, contractor disclosures, and misaligned regulatory timelines create prior-art risks and patent forfeiture scenarios that many companies fail to anticipate. This analysis examines how strategic patent filing coordination with foreign Phase I development can preserve
United States IP
FH
Foley Hoag LLP
See more
Article
One Image Can Create A Copyright Problem: What Businesses Should Know Before Using Photos In Marketing
A federal copyright case over a single Facebook photograph resulted in years of litigation despite a $200 damages award, demonstrating how routine image use in business marketing can create substantial legal and financial exposure. Understanding copyright compliance, licensing requirements, and proper image-sourcing procedures has become essential for businesses seeking to avoid costly infringement disputes.
United States IP
K
Klemchuk
Article
Fair Use Or Fair Game? Navigating Copyright In Influencer Culture
As digital influencers increasingly incorporate copyrighted music, video clips, and images into their content, the legal boundaries of fair use have become critically important. This analysis examines the four-factor fair use test and reveals common misconceptions that put content creators at risk of copyright infringement. Understanding these legal principles is essential for influencers who monetize their content through ads, sponsorships, and affiliate links.
United States IP
LD
Lerner David
See more
Article
The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print
Researchers routinely use AI tools like AlphaFold and Schrödinger's software without scrutinizing license agreements that contain restrictions on commercial use, confidentiality, and mandatory disclosure requirements. These overlooked terms can create significant legal obstacles when translating academic innovations into commercial products, affecting everything from sponsored research agreements to patent filings and university spinouts.
United States IP
FH
Foley Hoag LLP
Article
AI In The Art Market, Part 3: Human Creativity And Authenticity
As AI-generated art becomes increasingly sophisticated and visible in institutions like Dataland, the art world grapples with fundamental questions about distinguishing human creativity from machine output. This analysis explores the legal, commercial, and reputational implications for copyright protection, market positioning, disclosure obligations, and the evolving regulatory landscape surrounding AI use in creative industries.
United States IP
HK
Holland & Knight
Article
Intellectual Property Report
From Lululemon's strategic response to dupe culture to landmark trade dress victories and AI-powered patent analysis, this intellectual property report examines how brands are adapting their protection strategies in an era of social media influence and technological transformation. The collection explores critical developments in trademark law, patent prosecution, and the evolving intersection of artificial intelligence with IP due diligence.
United States IP
BB
Baker Botts LLP
See more
Article
AI-Assisted Inventions: Human Inventorship And USPTO Disclosure Duties
Quick Answer: AI-assisted inventions use the same U.S. inventorship standard as other inventions, with only human beings eligible as inventors. Technology companies should document each person's conception of the claimed invention before drafting claims and approving inventor declarations. The USPTO imposes no general AI-use disclosure duty, but information material to patentability can still require disclosure. [2] Patent counsel should assess inventorship, disclosure, and eligibility separately before the company commits to a filing strategy.
United States Technology
Novak Druce Carroll
Article
UK High Court Upholds Takeda’s Lisdexamfetamine SPC: Will The CJEU Agree?
The UK High Court has ruled on whether lisdexamfetamine (LDX), a pro-drug with no therapeutic activity before conversion to dextroamphetamine, can be considered an "active ingredient" for supplementary protection certificate purposes. This decision addresses a critical question in pharmaceutical patent law that has produced divergent outcomes across European jurisdictions and is currently before the CJEU in multiple pending referrals.
United States IP
JA
J A Kemp LLP
Article
The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print
Researchers routinely use AI tools like AlphaFold and Schrödinger's software without scrutinizing license agreements that contain restrictions on commercial use, confidentiality, and mandatory disclosure requirements. These overlooked terms can create significant legal obstacles when translating academic innovations into commercial products, affecting everything from sponsored research agreements to patent filings and university spinouts.
United States IP
FH
Foley Hoag LLP
See more
Article
Texas Court Of Appeals Affirms Business Court’s Denial Of Trade Secret Injunction In Autonomous Trucking Dispute
In CreateAI Holdings, Inc. f/k/a TuSimple Holdings, Inc. v. Bot Auto TX Inc., the Fifteenth Court of Appeals affirmed a Texas Business Court’s denial of a temporary injunction in an autonomous trucking trade secret dispute. The court’s memorandum opinion recognizes that mere suspicion and a competitor’s rapid success are insufficient to warrant injunctive relief. Instead, plaintiffs must produce evidence that specific, protectable secrets existed and were actually misappropriated.
United States IP
GT
Greenberg Traurig, LLP
Article
USPTO And Federal Circuit Decisions Reveal Patent Eligibility Parameters For AI Use
As businesses rapidly adopt artificial intelligence, machine learning, and predictive analytics across their operations, many overlook critical intellectual property considerations. Recent federal court decisions reveal the nuanced distinction between simply automating existing processes with AI versus creating patentable innovations that improve how AI systems themselves operate.
United States IP
RB
Reinhart Boerner Van Deuren s.c.
See more
See more
Is Traditional IP Enforcement Enough Protection In Vietnam’s Rapidly Digitalizing Economy? (Video)
G
Gamma Law